Natco Pharma - News
NSE: NATCOPHARM | BSE: 524816
₹785.05
As on 16-Oct-2026IST
Market cap
₹15,404 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13.5
P/B Ratio
1.6
Div. Yield
0.6 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Of Record Date For Rights Issue
25-Sep-2026No News & Announcements are available.